You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

melanoma cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Melanoma Trial in New Brunswick (Propranolol, Naltrexone)

Not yet recruiting
  • Advanced Melanoma
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jul 18, 2023

Melanoma, Urothelial Carcinoma Trial in China (QLF31907)

Not yet recruiting
  • Melanoma
  • Urothelial Carcinoma
  • Beijing, Beijing, China
  • +5 more
Apr 9, 2023

Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma

Recruiting
  • Clinical Stage I Cutaneous Melanoma AJCC v8
  • +13 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 16, 2022

Unresectable Melanoma, Metastatic Melanoma, Stage III NSCLC Trial in Louisville, New York (IOV-4001)

Recruiting
  • Unresectable Melanoma
  • +3 more
  • IOV-4001
  • Louisville, Kentucky
  • +2 more
Nov 21, 2022

Melanoma (Skin), Skin Cancer, Skin Melanoma Trial in Tampa (Vemurafenib, Cobimetinib)

Recruiting
  • Melanoma (Skin)
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Dec 30, 2022

Metastatic Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Portland (GB1211, Pembrolizumab, Placebo)

Not yet recruiting
  • Metastatic Melanoma
  • Head and Neck Squamous Cell Carcinoma
  • Portland, Oregon
    Providence Portland Medical Center
Jun 19, 2023

Metastatic Uveal Melanoma Trial in Grand Rapids (IDE196, Crizotinib, Pembrolizumab)

Recruiting
  • Metastatic Uveal Melanoma
  • Grand Rapids, Michigan
    The Cancer and Hematology Centers
Aug 14, 2023

Tumor Infiltrating Lymphocytes, Safety, Melanoma Trial in Beijing (GC101 TIL)

Recruiting
  • Tumor Infiltrating Lymphocytes
  • +4 more
  • GC101 TIL
  • Beijing, China
    Beijing Cancer Hospital
Nov 7, 2023

Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma Trial in Tampa (TBio-4101, Cyclophosphamide, Fludarabine)

Recruiting
  • Metastatic Melanoma
  • +9 more
  • TBio-4101
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 24, 2023

Clinical, Laboratory, and Epidemiologic Characterization of

Recruiting
  • Melanoma
  • Dysplastic Nevus Syndrome
    • Bethesda, Maryland
    • +1 more
    Jan 18, 2023

    Melanoma (Skin) Trial in Houston (BMS-986213 (Relatlimab-Nivolumab FDC), Nivolumab, Relatlimab)

    Not yet recruiting
    • Melanoma (Skin)
    • BMS-986213 (Relatlimab-Nivolumab FDC)
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 1, 2023

    Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma

    Recruiting
    • Clinical Stage I Cutaneous Melanoma AJCC v8
    • +33 more
    • Informational Intervention
    • +4 more
    • Los Angeles, California
    • +4 more
    Dec 14, 2022

    Sentinel Lymph Node, Melanoma (Skin), Breast Cancer Trial in Atlanta, Poughkeepsie, Hershey (IC-Green KIT)

    Completed
    Has Results
    • Sentinel Lymph Node
    • +2 more
    • IC-Green KIT
    • Atlanta, Georgia
    • +2 more
    Dec 19, 2022

    Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Los Angeles

    Recruiting
    • Clinical Stage IV Cutaneous Melanoma AJCC v8
    • +3 more
    • Magnetic Resonance Imaging using 7 Tesla MRI
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Nov 12, 2022

    Melanoma, Metastatic Melanoma Trial in Boston (CDX-301, NEOVAX, Nivolumab)

    Recruiting
    • Melanoma
    • Metastatic Melanoma
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 12, 2023

    Skin Cancer, Melanoma Trial in Stockholm (AI assistance)

    Enrolling by invitation
    • Skin Cancer
    • Melanoma
    • AI assistance
    • Stockholm, Sweden
      Karolinska University Hospital
    Oct 6, 2023

    A Storage Facility for Tissues Obtained From Malignant Melanoma

    Recruiting
    • Melanoma
    • Biospecimen Collection
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Nov 6, 2022

    Melanoma Trial (Cancer Patients Better Life Experience (CAPABLE))

    Not yet recruiting
    • Melanoma
    • Cancer Patients Better Life Experience (CAPABLE)
    • (no location specified)
    Apr 11, 2023

    TRAQinform Assessment of Immunotherapy Response

    Not yet recruiting
    • Melanoma
    • Non-Interventional
    • (no location specified)
    Apr 6, 2023

    Profiling of Pembrolizumab and Nivolumab in Melanoma and/or

    Active, not recruiting
    • Lung Non-Small Cell Carcinoma
    • Melanoma
    • Biospecimen Collection
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Feb 13, 2023

    Uveal Melanoma Trial in Minneapolis (PAC-1, Entrectinib)

    Active, not recruiting
    • Uveal Melanoma
    • Minneapolis, Minnesota
      HealthPartners Institute Regions Cancer Care Center
    Nov 15, 2022

    Malignant Melanoma Trial in United States (UV1, GM-CSF)

    Active, not recruiting
    • Malignant Melanoma
    • Santa Monica, California
    • +3 more
    Nov 16, 2022

    Anal Melanoma, Bladder Melanoma, Cervical Melanoma Trial in United States (Cabozantinib S-malate, Nivolumab, Placebo

    Recruiting
    • Anal Melanoma
    • +18 more
    • Cabozantinib S-malate
    • +5 more
    • Los Angeles, California
    • +53 more
    Jan 31, 2023

    Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma

    Recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +20 more
    • Neoantigen Peptide Vaccine
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Sep 7, 2022

    Melanoma Trial in Beijing (KD6001, Toripalimab)

    Not yet recruiting
    • Melanoma
    • Beijing, China
      Beijing Cancer Hospital
    Feb 3, 2023